Know Cancer

or
forgot password

"Kan IUGR og præeclampsi Forudsiges ud Fra YKL-40 målt i Serum?" "Metoder Til at Vurdere om Den Gravide Har Risiko for at Udvikle Svangerskabsforgiftning og/Eller væksthæmning Hos Fosteret".


N/A
18 Years
50 Years
Open (Enrolling)
Female
Intrauterine Growth Restriction, Preeclampsia

Thank you

Trial Information

"Kan IUGR og præeclampsi Forudsiges ud Fra YKL-40 målt i Serum?" "Metoder Til at Vurdere om Den Gravide Har Risiko for at Udvikle Svangerskabsforgiftning og/Eller væksthæmning Hos Fosteret".


Inclusion Criteria:



- Pregnant danish speeking women

Exclusion Criteria:

- Conditions/diseases involving chronical inflammation, or immunological activity

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Estrid Høgdall, PhD leader

Investigator Role:

Study Director

Investigator Affiliation:

Dept of Pathology Herlev Hospital, Denmark

Authority:

Denmark: The Regional Committee on Biomedical Research Ethics

Study ID:

SJ-55

NCT ID:

NCT00836524

Start Date:

January 2009

Completion Date:

September 2012

Related Keywords:

  • Intrauterine Growth Restriction
  • Preeclampsia
  • IUGR
  • Preeclampsia
  • ultrasound
  • YKL-40
  • Fetal Growth Retardation
  • Pre-Eclampsia

Name

Location